These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7900093)

  • 1. Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).
    Srivastava S; Joshi CS; Sethi PP; Agrawal AK; Srivastava SK; Seth PK
    Thromb Res; 1994 Dec; 76(5):451-61. PubMed ID: 7900093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients.
    Rabini RA; Ferretti G; Galassi R; Taus M; Curatola G; Tangorra A; Fumelli P; Mazzanti L
    Clin Biochem; 1994 Oct; 27(5):381-5. PubMed ID: 7867216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte individual phospholipids and erythrocyte membrane fluidity in subjects with vascular atherosclerotic disease with and without diabetes mellitus of type 2.
    Caimi G; Serra A; Catania A; D'Asaro S; Montana M; Lo Presti R; Sarno A
    Microcirc Endothelium Lymphatics; 1990; 6(2-3):149-57. PubMed ID: 2247023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.
    Hochgraf E; Levy Y; Aviram M; Brook JG; Cogan U
    Metabolism; 1994 Jan; 43(1):11-7. PubMed ID: 8289667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological determinants and red cell lipidic pattern in essential obesity, in obese subjects with non-insulin-dependent diabetes mellitus (NIDDM) and in obese subjects with impaired glucose tolerance (IGT).
    Caimi G; Lo Presti R; Serra A; Catania A; D'Asaro S; Verga S; Buscemi S; Sarno A
    Microcirc Endothelium Lymphatics; 1991; 7(4-6):293-304. PubMed ID: 1815108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus.
    Tong P; Thomas T; Berrish T; Humphriss D; Barriocanal L; Stewart M; Walker M; Wilkinson R; Alberti KG
    Lancet; 1995 Feb; 345(8946):357-8. PubMed ID: 7845118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease.
    Bordia A; Verma SK; Srivastava KC
    Prostaglandins Leukot Essent Fatty Acids; 1997 May; 56(5):379-84. PubMed ID: 9175175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in membrane microenvironment and signal transduction in platelets from NIDDM patients-a pilot study.
    Srivastava K; Dash D
    Clin Chim Acta; 2002 Mar; 317(1-2):213-20. PubMed ID: 11814478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cellular Ca2+ and Na+ transport in diabetes mellitus.
    Mazzanti L; Rabini RA; Faloia E; Fumelli P; Bertoli E; De Pirro R
    Diabetes; 1990 Jul; 39(7):850-4. PubMed ID: 2162303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications.
    Caimi G; Lo Presti R; Montana M; Canino B; Ventimiglia G; Romano A; Catania A; Sarno A
    Diabetes Care; 1995 Jan; 18(1):60-3. PubMed ID: 7698049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid fluidity modulates platelet aggregation and agglutination in vitro.
    Vlasic N; Medow MS; Schwarz SM; Pritchard KA; Stemerman MB
    Life Sci; 1993; 53(13):1053-60. PubMed ID: 8366768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients.
    Peuchant E; Delmas-Beauvieux MC; Couchouron A; Dubourg L; Thomas MJ; Perromat A; Clerc M; Gin H
    Diabetes Care; 1997 Feb; 20(2):202-7. PubMed ID: 9118775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension.
    Caimi G; Lo Presti R; Montana M; Contorno A; Canino B; Catania A; Sarno A; Cerasola G
    Am J Hypertens; 1995 Jan; 8(1):82-6. PubMed ID: 7734103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies.
    Wu HP; Tai TY; Chuang LM; Lin BJ; Wang JD; Teng CM
    J Formos Med Assoc; 1992 Mar; 91(3):270-5. PubMed ID: 1354687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects.
    Winocour PD; Watala C; Kinglough-Rathbone RL
    Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
    Caimi G; Canino B; Montana M; Catania A; Lo Presti R
    Thromb Haemost; 1999 Jul; 82(1):149. PubMed ID: 10456470
    [No Abstract]   [Full Text] [Related]  

  • 19. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation.
    Fukuda K; Ozaki Y; Satoh K; Kume S; Tawata M; Onaya T; Sakurada K; Seto M; Sasaki Y
    Diabetes; 1997 Mar; 46(3):488-93. PubMed ID: 9032107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.